BRIEF-Lexicon Announces Receipt Of Complete Response Letter For Zynquista (Sotagliflozin)

Reuters
21 Dec 2024
BRIEF-Lexicon Announces Receipt Of Complete Response Letter For Zynquista (Sotagliflozin)

Dec 20 (Reuters) - Lexicon Pharmaceuticals Inc LXRX.O:

  • LEXICON ANNOUNCES RECEIPT OF COMPLETE RESPONSE LETTER FOR ZYNQUISTA™ (SOTAGLIFLOZIN)

  • LEXICON PHARMACEUTICALS INC - TO DISCONTINUE ZYNQUISTA LAUNCH PREPARATIONS

Source text: ID:nGNX5RYqVS

Further company coverage: LXRX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10